Preo Pharma ApS: Financial statements 2021
CVR: 41191007
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Preo Pharma ApS (CVR 41191007) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 294,880 and a net result of DKK 188,655 compared with DKK -120,084 the year before. Equity in the 2021 report amounted to DKK 108,571. The solvency ratio was 28.8%.
- Gross Profit
- DKK 294,880
- Profit/Loss
- DKK 188,655
- Equity
- DKK 108,571
- Total Assets
- DKK 376,735
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 295 t. | 189 t. | 109 t. | - |
| 2020 | - | -161 t. | -120 t. | -80 t. | - |
Official annual report
Find more companies like Preo Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Preo Pharma ApS has published its interim report for the period February 24, 2020 – December 31, 2020.
As of February 24, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Preo Pharma ApS.
About Preo Pharma ApS
Preo Pharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company has been dissolved on 6 October 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2022, the company reported a gross profit of DKK -41,283 and a net result of DKK -54,301 compared with DKK 188,655 the year before. Equity in the 2022 report amounted to DKK 54,270.